College of New Caledonia (CNC) has awarded a $5,000 scholarship to first-year nursing baccalaureate student Wynne Fitzpatrick ...
Persistent care barriers may lead patients with inflammatory bowel disease (IBD) to ration medication or skip doses. The ...
Access to data and to skills specific to AI are among the key challenges pharma companies face to unlock the technology’s ...
Researchers have found in a new study that common antibiotic Vancomycin may also be effective in treating individuals with a ...
Despite advances in treatment for inflammatory bowel disease, more than 55% of patients report medication delays, mostly due ...
A study led by the University of Birmingham found that vancomycin, a commonly used antibiotic for diarrhea, could effectively treat a type of inflammatory bowel disease (IBD) linked to autoimmune ...
Vancomycin could offer new therapeutic option for patients with a type of inflammatory bowel disease
An antibiotic used to treat infective diarrhoea could be an effective drug for a type of inflammatory bowel disease, a new study has found.
An antibiotic used to treat infective diarrhea could be an effective drug for a type of inflammatory bowel disease, a new ...
The Levy family is excited to be recognized as the 2025 New England Take Steps Honored Family, and Soliel as the Honored Hero ...
For older adults with inflammatory bowel disease (IBD), there was no significant difference in the risk of major ...
Older adults with moderate to severe IBD can achieve remission with JAK inhibitors, according to a study presented at Crohn’s & Colitis Congress.
Better cardiovascular safety and lower risk of all-cause mortality was observed among older adult patients with IBD who received ustekinumab vs vedolizumab.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback